Company lists · Data refreshed September 2026

Top 25 Immunotherapy venture capital companies worldwide

Name: Immunotherapy venture capital companies worldwide
Creator: RevenueBase
License: https://creativecommons.org/licenses/by/4.0/

Compiled by the RevenueBase Data Team Data refreshed Sep 3, 2026 1,063 companies tracked

RevenueBase identified 1,063 immunotherapy venture capital companies worldwide as of September 2026 and tracks 35,222 professional contacts across them, including 18,325 with verified work emails and 11,734 with mobile numbers. The United States is the largest market and Cambridge the largest hub.

This list covers immunotherapy venture capital companies worldwide, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 3, 2026. Country and city lists for immunotherapy venture capital companies follow the table.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 3, 2026 86% judged on-target in blind review

1,063Companies

35,222Contacts tracked

18,325Verified emails

11,734Mobile numbers

Explore this list → Free signup · no credit card · 500 free credits

The 25 largest immunotherapy venture capital companies worldwide

Ranked by team size

Top 25 of 1,063 immunotherapy venture capital companies worldwide, ranked by team size, largest first. Data refreshed Sep 3, 2026. RevenueBase Smart Search rates how each company's information relates to immunotherapy venture capital companies: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#	Company	RevenueBase Smart Search	Headquarters	Employees	Contacts
1	Biontech SE	Partial evidence	Mainz, GermanyHQ checked Sep 3, 2026	1,001-5,000	4,503 contacts →
	Partial evidence “Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full…” Source: RevenueBase Database · checked Sep 3, 2026
2	Kite Pharma	Indirect evidence	Santa Monica, MD, United StatesHQ checked Sep 3, 2026	1,001-5,000	3,768 contacts →
	Indirect evidence “At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy.” Source: RevenueBase Database · checked Sep 3, 2026
3	Iovance Biotherapeutics, INC	Indirect evidence	San Carlos, PA, United StatesHQ checked Sep 3, 2026	501-1,000	981 contacts →
	Indirect evidence “Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 3, 2026
4	Blueprint Medicines	Indirect evidence	Cambridge, MA, United StatesHQ checked Sep 3, 2026	501-1,000	799 contacts →
	Indirect evidence “Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines.” Source: RevenueBase Database · checked Sep 3, 2026
5	Autolus Therapeutics	Indirect evidence	London, United KingdomHQ checked Sep 3, 2026	501-1,000	763 contacts →
	Indirect evidence “Autolus is a CAR T cell therapy company.” Source: RevenueBase Database · checked Sep 3, 2026
6	Adaptive Biotechnologies Corp	Indirect evidence	Seattle, CA, United StatesHQ checked Sep 3, 2026	501-1,000	695 contacts →
	Indirect evidence “Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.” Source: RevenueBase Database · checked Sep 3, 2026
7	Dendreon	Partial evidence	Seal Beach, WA, United StatesHQ checked Sep 3, 2026	501-1,000	632 contacts →
	Partial evidence “Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.” Source: RevenueBase Database · checked Sep 3, 2026
8	Immunitybio, INC	Partial evidence	San Diego, CA, United StatesHQ checked Sep 3, 2026	501-1,000	592 contacts →
	Partial evidence “ImmunityBio, Inc.(formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially…” Source: RevenueBase Database · checked Sep 3, 2026
9	Immunocore	Indirect evidence	Abingdon, MD, United KingdomHQ checked Sep 3, 2026	201-500	578 contacts →
	Indirect evidence “Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as…” Source: RevenueBase Database · checked Sep 3, 2026
10	Immatics	Indirect evidence	Tuebingen, GermanyHQ checked Sep 3, 2026	501-1,000	568 contacts →
	Indirect evidence “Immatics is committed to making a meaningful impact on the lives of patients with cancer.” Source: RevenueBase Database · checked Sep 3, 2026
11	Replimune	Indirect evidence	Woburn, MA, United StatesHQ checked Sep 3, 2026	201-500	463 contacts →
	Indirect evidence “Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response.” Source: RevenueBase Database · checked Sep 3, 2026
12	Hutchmed	Indirect evidence	Florham Park, NJ, Hong KongHQ checked Sep 3, 2026	1,001-5,000	457 contacts →
	Indirect evidence “HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.” Source: RevenueBase Database · checked Sep 3, 2026
13	Leti Pharma	Indirect evidence	Tres Cantos, SpainHQ checked Sep 3, 2026	201-500	418 contacts →
	Indirect evidence “LETI Pharma, the Experimental Laboratory for Immunogenic Therapeutics, is an independent, family-owned, biopharmaceutical company.” Source: RevenueBase Database · checked Sep 3, 2026
14	Allergy Therapeutics	Indirect evidence	Worthing, United KingdomHQ checked Sep 3, 2026	501-1,000	349 contacts →
	Indirect evidence “Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments.” Source: RevenueBase Database · checked Sep 3, 2026
15	Zymeworks INC	Indirect evidence	Vancouver, BC, CanadaHQ checked Sep 3, 2026	201-500	320 contacts →
	Indirect evidence “Zymeworks is a global biotechnology company developing and managing a portfolio of differentiated biotherapeutics to improve the standard of care for patients with…” Source: RevenueBase Database · checked Sep 3, 2026
16	Adaptimmune	Indirect evidence	Abingdon, MA, United KingdomHQ checked Sep 3, 2026	201-500	314 contacts →
	Indirect evidence “Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K- and U.S-based biotechnology hub locations.” Source: RevenueBase Database · checked Sep 3, 2026
17	Vividion Therapeutics, INC	Indirect evidence	San Diego, CA, United StatesHQ checked Sep 3, 2026	201-500	273 contacts →
	Indirect evidence Source: RevenueBase Database · checked Sep 3, 2026
18	Allogene Therapeutics	Indirect evidence	South San Francisco, CA, United StatesHQ checked Sep 3, 2026	201-500	247 contacts →
	Indirect evidence “Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T…” Source: RevenueBase Database · checked Sep 3, 2026
19	Vera Therapeutics, INC	Indirect evidence	Brisbane, CA, United StatesHQ checked Sep 3, 2026	201-500	222 contacts →
	Indirect evidence Source: RevenueBase Database · checked Sep 3, 2026
20	Lyell Immunopharma	Indirect evidence	South San Francisco, CA, United StatesHQ checked Sep 3, 2026	201-500	212 contacts →
	Indirect evidence “Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 3, 2026
21	Transgene	Partial evidence	Illkirch-Graffenstaden, FranceHQ checked Sep 3, 2026	51-200	207 contacts →
	Partial evidence “Cancer immunotherapy Transgene (Euronext: TNG) is a clinical-stage biotechnology company focused on individualized therapeutic vaccines” Source: RevenueBase Database · checked Sep 3, 2026
22	Umoja Biopharma	Indirect evidence	Seattle, WA, United StatesHQ checked Sep 3, 2026	51-200	202 contacts →
	Indirect evidence “Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.” Source: RevenueBase Database · checked Sep 3, 2026
23	Innate Pharma	Indirect evidence	Marseille, MD, FranceHQ checked Sep 3, 2026	201-500	197 contacts →
	Indirect evidence “Innate Pharma S.A.” Source: RevenueBase Database · checked Sep 3, 2026
24	Atara Biotherapeutics	Partial evidence	Thousand Oaks, CA, United StatesHQ checked Sep 3, 2026	201-500	193 contacts →
	Partial evidence “Atara Biotherapeutics Inc, is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious…” Source: RevenueBase Database · checked Sep 3, 2026
25	Tscan Therapeutics	Indirect evidence	Waltham, MA, United StatesHQ checked Sep 3, 2026	51-200	190 contacts →
	Indirect evidence “TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.” Source: RevenueBase Database · checked Sep 3, 2026

RevenueBase Smart Search

RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: immunotherapy venture capital companies. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.

Strong evidence: The company's own public description of its business names immunotherapy venture capital companies.
Partial evidence: Its own public description names part of immunotherapy venture capital companies, so it works in or next to the category without describing itself that way.
Indirect evidence: The description shown does not name immunotherapy venture capital companies. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.

RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.

Showing 25 of 1,063 immunotherapy venture capital companies worldwide

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 18,325 reachable decision-makers.

Free signup · no credit card

View the full list →

Immunotherapy venture capital companies worldwide at a glance

As of Sep 3, 2026

52.0%Verified-email coverage

33.3%Mobile-number coverage

33.1Average contacts per company

11-50Median size (employees)

5.3%Largest-city concentration · Cambridge

Sep 3, 2026Page data refreshed

Companies by employee count

1-10

486

11-50

365

51-200

159

201-500

501-1,000

1,001-5,000

10001+

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source: The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
Coverage: 9 countries, largest first: the United States, China, the United Kingdom, France, Germany, Canada, Switzerland, Australia, Spain. Country and city lists for immunotherapy venture capital companies are linked below.
What qualifies: Companies worldwide whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search: RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names immunotherapy venture capital companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude: Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email.
Match quality: In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking: Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification: Every listed company carries at least one verified work email, 18,325 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh: This page's figures were pulled from the company graph between September 3, 2026 and September 14, 2026. Lists refresh periodically as the graph is re-checked.
Corrections: Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Immunotherapy venture capital companies by location

16 lists · largest first

Every Immunotherapy venture capital companies list RevenueBase publishes, by country and city. Counts are matching companies in each list as of its own refresh date.

Countries

Cities

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names immunotherapy venture capital companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many immunotherapy venture capital companies are there worldwide?

RevenueBase identified 1,063 immunotherapy venture capital companies worldwide as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Biontech SE, headquartered in Idar-Oberstein, tops this list with the largest team on record.

Which country has the most immunotherapy venture capital companies?

The United States leads with 663 companies, followed by China (80) and the United Kingdom (77). Every immunotherapy venture capital companies list by country and city is linked on this page.

Which city has the most immunotherapy venture capital companies?

Cambridge leads with 56 headquartered companies, followed by San Diego (49) and Boston (39).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 18,325 verified decision-maker contacts tracked across these 1,063 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled from the company graph between September 3, 2026 and September 14, 2026.

Ready to reach these companies? Verified emails and direct dials for all 1,063 immunotherapy venture capital companies worldwide. Start with a free account, no credit card.

Download this list →

Related lists

Browse the directory

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.